GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Bonesupport Holding AB (CHIX:BONEXs) » Definitions » ROE % Adjusted to Book Value

Bonesupport Holding AB (CHIX:BONEXS) ROE % Adjusted to Book Value : 0.61% (As of Mar. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Bonesupport Holding AB ROE % Adjusted to Book Value?

Bonesupport Holding AB's ROE % for the quarter that ended in Mar. 2024 was 15.61%. Bonesupport Holding AB's PB Ratio for the quarter that ended in Mar. 2024 was 25.43. Bonesupport Holding AB's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2024 was 0.61%.


Bonesupport Holding AB ROE % Adjusted to Book Value Historical Data

The historical data trend for Bonesupport Holding AB's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bonesupport Holding AB ROE % Adjusted to Book Value Chart

Bonesupport Holding AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
ROE % Adjusted to Book Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only - -3.15 -2.44 -1.33 3.43

Bonesupport Holding AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.02 0.26 13.87 0.46 0.61

Competitive Comparison of Bonesupport Holding AB's ROE % Adjusted to Book Value

For the Medical Instruments & Supplies subindustry, Bonesupport Holding AB's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bonesupport Holding AB's ROE % Adjusted to Book Value Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Bonesupport Holding AB's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Bonesupport Holding AB's ROE % Adjusted to Book Value falls into.



Bonesupport Holding AB ROE % Adjusted to Book Value Calculation

Bonesupport Holding AB's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=60.19% / 17.54
=3.43%

Bonesupport Holding AB's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2024 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=15.61% / 25.43
=0.61%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Bonesupport Holding AB ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Bonesupport Holding AB's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Bonesupport Holding AB (CHIX:BONEXS) Business Description

Traded in Other Exchanges
Address
Scheelevagen 19, Lund, SWE, SE-223 70
Bonesupport Holding AB is a fast-growing ortho-biologics company that focuses on the treatment of bone disorders. The Company develops and sells injectable bio-ceramic bone graft substitutes based on its CERAMENT platform, which remodels to bone and has the ability to release pharmaceuticals to promote healing. Its products focus on trauma, revision arthroplasty (replacement of joint prostheses), chronic osteomyelitis (bone infection), and foot and ankle surgery. The Group manages and monitors operations in two operating segments: North America (NA) and Europe & Rest of the World (EUROW).

Bonesupport Holding AB (CHIX:BONEXS) Headlines

No Headlines